Company Filing History:
2 out of 550 
2 out of 96 
Years Active: 2020
Title: Vivek Saroj Kumar Chopra: Innovator in Cancer Treatment
Introduction
Vivek Saroj Kumar Chopra is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of oncology, particularly in developing combination therapies for treating malignancies. With a total of 2 patents, his work focuses on innovative methods to combat cancers associated with specific genetic mutations.
Latest Patents
Chopra's latest patents include groundbreaking methods for treating cancers in patients with IDH2 and IDH1 mutations. The first patent outlines a combination therapy that utilizes an inhibitor of the mutant IDH2 enzyme alongside a DNA demethylating agent. The second patent presents a similar approach for hematological malignancies, employing a specific compound in conjunction with a DNA demethylating agent to target patients with IDH1 mutations.
Career Highlights
Throughout his career, Vivek has worked with prominent companies in the pharmaceutical industry, including Celgene Corporation and Agios Pharmaceuticals, Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to the advancement of cancer treatment.
Collaborations
Chopra has had the opportunity to work alongside talented individuals such as Jorge DiMartino and Laurie A Kenvin. These collaborations have further enriched his research and development efforts in the realm of oncology.
Conclusion
Vivek Saroj Kumar Chopra stands out as an innovative inventor dedicated to improving cancer treatment through his patented therapies. His work continues to impact the lives of patients facing malignancies, showcasing the importance of research and innovation in medicine.